Opinion | The fall of Chevron may affect business regulation. https://t.co/PZ5oI5tjd7
Navigating Antitrust Enforcement: The Supreme Court Decision on Chevron Doctrine https://t.co/1AXMW3M0BW | by @lhediscovery
Event in Review: Antitrust in Healthcare: The Good, the Bad, and the Ugly https://t.co/mH3SZoqUQ0 | by @venablellp
The Supreme Court's recent decision to end the Chevron Doctrine is poised to significantly impact regulatory accountability and business regulation. The Chevron Doctrine, which has long allowed federal agencies to interpret ambiguous statutes, is now under scrutiny. This change is expected to affect intellectual property (IP) and antitrust enforcement, with increased attention on third-party pricing facilitators. Legal experts from Goodwin Law and Venable LLP have highlighted the potential consequences for various sectors, including healthcare.
